DCC-3009

N/A

Report date: 2024/10/09 20:00:32
NME

Base Information

Drug NameDCC-3009
Drug Alias NameDCC-3009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsGastrointestinal Stromal Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDeciphera Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeciphera Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsGastrointestinal Stromal Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A